As of 2026-09-20, the Relative Valuation of Charles River Laboratories International Inc (CRL) is (76.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 278.06 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -127.5%.
The range of the Relative Valuation is (138.71) - 13.77 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.0x - 39.0x | 33.3x |
| Forward P/E multiples | 21.6x - 27.2x | 24.2x |
| Fair Price | (138.71) - 13.77 | (76.44) |
| Upside | -149.9% - -95.0% | -127.5% |
| Date | P/E |
| 2026-09-18 | -56.17 |
| 2026-09-17 | -56.90 |
| 2026-09-16 | -55.23 |
| 2026-09-15 | -55.12 |
| 2026-09-14 | -55.17 |
| 2026-09-11 | -56.21 |
| 2026-09-10 | -55.15 |
| 2026-09-09 | -56.23 |
| 2026-09-08 | -56.72 |
| 2026-09-04 | -58.28 |
| 2026-09-03 | -59.26 |
| 2026-09-02 | -58.94 |
| 2026-09-01 | -57.03 |
| 2026-08-31 | -58.23 |
| 2026-08-28 | -58.88 |
| 2026-08-27 | -59.88 |
| 2026-08-26 | -59.61 |
| 2026-08-25 | -60.13 |
| 2026-08-24 | -60.32 |
| 2026-08-21 | -59.63 |
| 2026-08-20 | -58.87 |
| 2026-08-19 | -58.58 |
| 2026-08-18 | -56.40 |
| 2026-08-17 | -57.90 |
| 2026-08-14 | -56.57 |
| 2026-08-13 | -56.82 |
| 2026-08-12 | -57.44 |
| 2026-08-11 | -56.97 |
| 2026-08-10 | -55.96 |
| 2026-08-07 | -54.03 |
| 2026-08-06 | -53.63 |
| 2026-08-05 | -52.67 |
| 2026-08-04 | -47.29 |
| 2026-08-03 | -46.64 |
| 2026-07-31 | -46.97 |
| 2026-07-30 | -47.39 |
| 2026-07-29 | -47.43 |
| 2026-07-28 | -48.57 |
| 2026-07-27 | -45.31 |
| 2026-07-24 | -45.77 |
| 2026-07-23 | -46.32 |
| 2026-07-22 | -44.18 |
| 2026-07-21 | -44.32 |
| 2026-07-20 | -44.38 |
| 2026-07-17 | -45.32 |
| 2026-07-16 | -46.29 |
| 2026-07-15 | -46.10 |
| 2026-07-14 | -46.71 |
| 2026-07-13 | -46.41 |
| 2026-07-10 | -47.15 |